TNF-α/IL-2 Ratio Discriminates Latent from Active Tuberculosis in Immunocompetent Children: a Pilot Study
Overview
Authors
Affiliations
Background: Distinguishing latent tuberculosis (LTB) from tuberculosis (TB) disease may be challenging in children. Here, we analyzed cytokine profiles that can distinguish the two infection stages in a nonendemic country (France).
Methods: Immunocompetent children with LTB (n = 6) or TB disease (n = 8) (median age: 6.2 and 5.7 years, respectively) were analyzed. Four young uninfected children were included as controls. A Luminex assay evaluated cytokine responses to Mycobacterium tuberculosis antigens.
Results: Poor interleukin-4 (IL-4) and IL-10 responses precluded analysis of these cytokines. Interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), IL-2, and T-helper type 1 (Th1) cytokines and IL-5, IL-13, T-helper type 2 (Th2) cytokines were simultaneously induced by antigens in 14/14 infected but 0/4 uninfected children. Th1 cytokine levels were similar in LTB and TB disease: IFN-γ: 12,254 and 10,495 pg/ml; IL-2: 2,097 and 1,869 pg/ml; and TNF-α: 1,020 and 2,875 pg/ml, respectively. Th2 cytokine levels were similar and even higher in LTB than in TB disease: IL-5: 23 and 10 pg/ml; IL-13: 284 and 109 pg/ml, respectively. Positive correlation of cytokine levels, whether Th1 or Th2, was observed. Higher (P = 0.008) TNF-α/IL-2 ratios distinguished 6/8 active TB disease cases from 6/6 LTB cases.
Conclusion: TNF-α/IL-2 ratio may discriminate TB disease from LTB in immunocompetent children. Larger studies in TB endemic settings must verify these results.
Zhang L, Li Y, Zou X, Ma H, Gao M, Ge Q Front Immunol. 2025; 15():1462222.
PMID: 39845975 PMC: 11751065. DOI: 10.3389/fimmu.2024.1462222.
Jeong J, Shim S, Han S, Hwang I, Ihm C Front Microbiol. 2025; 15:1506127.
PMID: 39760075 PMC: 11695403. DOI: 10.3389/fmicb.2024.1506127.
Njagi L, Nduba V, Murithi W, Mwongera Z, Cook K, Mecha J Sci Rep. 2025; 15(1):224.
PMID: 39748008 PMC: 11695726. DOI: 10.1038/s41598-024-83965-5.
Njagi L, Nduba V, Murithi W, Mwongera Z, Cook K, Mecha J Res Sq. 2024; .
PMID: 39606489 PMC: 11601854. DOI: 10.21203/rs.3.rs-4815117/v1.
Challenges and the Way forward in Diagnosis and Treatment of Tuberculosis Infection.
Chin K, Anibarro L, Sarmiento M, Acosta A Trop Med Infect Dis. 2023; 8(2).
PMID: 36828505 PMC: 9960903. DOI: 10.3390/tropicalmed8020089.